News search

E.g., 16/06/2025
E.g., 16/06/2025
Sarai Martínez Cano, Marcos Femenía Muiña, Elena Hernández, Vanessa Núñez, Manuel Rodrigo Tapias, Miguel Galán Burgos, Iñaki Robles,  Alberto Benguria, David Sancho y Almudena Ramiro
Research
2 Jun 2025

A team from the CNIC has discovered the key role of conventional type 1 dendritic cells (cDC1) in atherosclerosis and has developed an experimental therapy with immunosuppressive nanoparticles that slows the progression of the disease in animal models.

Jorge Nicolás Domínguez, Susana Temiño, Morena Raiola, Miquel Sendra y Miguel Torres.
Research
29 May 2025

CNIC researchers have discovered that the heart is formed from two independent cell types that act in synchrony from the onset of gastrulation. This finding could help to better understand the origin of certain congenital heart defects and open up new opportunities in regenerative medicine and tissue bioengineering.

David Sancho, Ignacio Heras-Murillo y Stefanie Wculek.
Research
14 Apr 2025

A study led by the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), in collaboration with the Instituto de Investigación Biomédica de Barcelona (IRB Barcelona), has identified the most effective subtype of dendritic cell for generating immune memory in response to cancer

Dr. Giuseppe Danilo Norata
About the CNIC
3 Apr 2025

Dr. Giuseppe Danilo Norata is a Full Professor of Pharmacology at the Department of Excellence of Pharmacological and Biomolecular Sciences, University of Milan

Prof. Yasuyuki Fujita, PhD, Kyoto University Graduate School of Medicine, Department of Molecular Oncology
About the CNIC
26 Mar 2025

Prof. Yasuyuki Fujita, PhD, Kyoto University Graduate School of Medicine, Department of Molecular Oncology

3D reconstruction of the collagen ring (in orange) produced by neutrophils, which forms around wounds in the skin.
Research
19 Mar 2025

The discovery, published in Nature, opens the path to new strategies for treating skin diseases and immunological disorders, with special potential for the treatment of inflammation, diabetes, and age-related conditions

Isabel Gonçalves es profesora y consultora senior en la Universidad de Lund (Suecia)
Research
11 Mar 2025

Isabel Gonçalves is a professor and senior consultant at the University of Lun (Sweden). Her research focuses on cardiovascular disease and diabetes. She is the principal investigator in EXODIAB (Excellence in Diabetes Research in Sweden), leads a team at Cardiovascular Research - Translational Studies, and is a researcher in EpiHealth, a project focused on epidemiology for health.

From left to right: D. MacGrogan, B. Flores-Garza, T. González-Costa, V. Sebastián-Serrano,  J.L. de la Pompa, L. Méndez-Peralta, A. Pau-Navalón, A. Galicia-Martín, J. Santos-Cantador,  C. Relaño-Ruperez, M. Siguero-Álvarez
About the CNIC
12 Dec 2024

The new project, ‘The Placenta in Maternal and Fetal Cardiovascular Health and Disease’, aims to understand how the placenta influences cardiovascular health in mothers and their children, promising improvements in the prevention and treatment of related diseases

Back row: Víctor Jiménez, Mónica Toledano, Miguel Ángel del Pozo Barriuso, María Aboy Pardal, Sara Terrés, Daniel Jiménez, Fidel Lolo. Front row: Miguel Sánchez, Mauro Catalá, Asier Echarri.
Research
28 Nov 2024

A study from the CNIC, published in Nature Communications, reveals how caveolae allow adipocytes to expand safely, storing fat without breaking or causing inflammation

Miguel Ángel del Pozo, Jorge Alegre-Cebollada, Carla Huerta-López, Alejandro Clemente-Manteca, Diana Velázquez-Carreras, and Elías Herrero-Galán.
Research
15 Nov 2024

A study by CNIC, published in Science Advances, offers a new approach to understanding how cells respond to mechanical signals from their environment, redefining the comprehension of the relationship between cells and their physical surroundings.